Alurion Resources Limited: Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

Highlights PFS studies underway: Alurion Resources Limited (ASX: ALU) has commenced infill drilling and bulk-sample trenching ...

Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

Jiayin Group Inc. ("Jiayin" or the "Company") (NASDAQ: JFIN), a leading fintech platform in China, today announced its ...

Cygnus Metals Limited: Drilling Results Update

Results from Copper Rand come from step out drilling surrounding the historic mine which produced 14.9Mt at 3.9% CuEq for ...

Solstice Advanced Materials, Inc.: Solstice Advanced Materials Announces Mutual Termination of Merger Agreement with Element Solutions

Board of Directors Authorizes $500 Million Share Repurchase Program Company Affirms Third Quarter and Full-Year 2026 Guidance MORRIS PLAINS, N.J., Aug. 27, 2026 /PRNewswire/ ...

Air New Zealand Slips To Loss In FY26, Despite Traffic, Capacity Growth

Air New Zealand Ltd (ANZLY, AIZ.AX) reporteda loss in fiscal 2026, compared to prior year's profit, adversely impacted by high fuel prices resulting from the Middle East conflict ...

Mutual Federal Bancorp, Inc. Announces Adoption of Plan of Conversion and Reorganization to Undertake Second Step Conversion

Mutual Federal Bancorp, Inc. (the "Company") (OTCID Market: "MFDB"), the holding company for Mutual Federal Bank (the "Bank") ...

IM Cannabis Corp.: IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the ...

Hangzhou Tigermed Consulting Co., Ltd.: Tigermed Announces 2026 Interim Results

Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical ...

Roivant Sciences: Roivant Announces FDA Approval of LISRAYA (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating ...

MADARA Cosmetics: MADARA Cosmetics turnover grows by 17.5% in the first half of 2026, EBITDA doubles

AS MADARA Cosmetics (hereinafter - the Group) achieved consolidated turnover of EUR 13.36 million in the first six months of 2026, representing a 17.5% increase compared with the corresponding period ...

Animal Disinfectants Market worth $6.69 billion by 2031- Exclusive Report by MarketsandMarkets

According to MarketsandMarkets, the animal disinfectants market is estimated at USD 4.51 billion in 2026 and is projected to reach USD 6.69 ...

HUTCHMED (China) Limited: HUTCHMED Announces NMPA Approval for ATLED (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (NDA) for ...